Andrew Obenshain - Dec 7, 2021 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Helen C. Fu, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Dec 7, 2021
Transactions value $
-$8,469
Form type
4
Date filed
12/9/2021, 03:51 PM
Previous filing
Nov 17, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Sale -$8.47K -832 -0.33% $10.18 254K Dec 7, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 The range in prices for the transaction reported on this line was $10.13 to $10.24. The average weighted price was $10.1794. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.